Country
China
City
Shanghai
Founded
2021
Headcount
11-50
Shanghai
Description
MindRank AI, a clinical-stage biotechnology company developing an artificial intelligence-powered drug research and development platform, announced that it has raised $52 million in Series B financing.
Funding history
-
Series B
Investors a group of institutional investors and healthcare-focused funds
MindRank AI, a clinical-stage biotechnology company developing an artificial intelligence-powered drug research and development platform, announced that it has raised $52 million in Series B financing.
—
Source
Founders
-
Zhangming Niu
Founder and Chief Executive Officer